Spero Therapeutics, Inc. (SPRO): Depreciation & Amortization
$0
Year ended 2025-12-31
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $0 | -100.0% | 2026-03-26, From 2025-01-01 |
| 2024-12-31 | $2.0K | -99.5% | 2026-03-26, From 2024-01-01 |
| 2023-12-31 | $367.0K | -57.8% | 2025-03-27, From 2023-01-01 |
| 2022-12-31 | $869.0K | +34.5% | 2024-03-13, From 2022-01-01 |
| 2021-12-31 | $646.0K | -15.1% | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | $761.0K | +1.5% | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | $750.0K | +83.4% | 2021-03-11, From 2019-01-01 |
| 2018-12-31 | $409.0K | +12.7% | 2020-03-16, From 2018-01-01 |
| 2017-12-31 | $363.0K | +30.1% | 2019-03-14, From 2017-01-01 |
| 2016-12-31 | $279.0K | n/m | 2019-03-14, From 2016-01-01 |
| 2015-12-31 | $11.0K | n/a | 2018-04-02, From 2015-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Spero Therapeutics, Inc. (SPRO) | 2025-12-31 | $0 | -100.0% |
| Enanta Pharmaceuticals Inc (ENTA) | 2025-09-30 | $4.59M | +96.3% |
| Rockwell Medical, Inc. (RMTI) | 2025-12-31 | $2.19M | +0.6% |
| Viridian Therapeutics, Inc. (VRDN) | 2025-12-31 | $460.0K | -14.8% |
| Nuvation Bio Inc. (NUVB) | 2025-12-31 | $1.74M | +154.6% |
| Assembly Biosciences, Inc. (ASMB) | 2025-12-31 | $129.0K | 0.0% |
| Bicycle Therapeutics PLC (BCYC) | 2025-12-31 | $6.42M | -10.5% |
| Aytu Biopharma, Inc (AYTU) | 2026-06-30 | $3.93M | -26.9% |
| Eton Pharmaceuticals, Inc. (ETON) | 2025-12-31 | $4.04M | +252.9% |
Compare SPRO, ENTA, RMTI, VRDN side by side · Screen every company in Pharmaceutical Preparations ↗